Arterial thromboembolism in patients with cancer and atrial fibrillation
Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...
ARCHIVE
Cancer-associated Thrombosis: Assessing and Addressing Unmet Needs and Inequalities in Patient Education and Awareness
The Problem The estimated incidence of cancer-associated thrombosis (CAT) is increasing over time and ranges from 1.6%...
Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
The Impact of DDI on the Cancer Patient
Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...
The prevalence of potential drug–drug interactions in cancer patients treated with anticoagulants
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Tzu-Fei Wang...
What do we know about bleeding risk in patients with cancer?
Venous thromboembolism (VTE) is a well-recognized complication in patients with cancer, with an increase in risk by a...
Management of the incidents of VTE in cancer patients
During the ICTHIC webinar, “Updates in cancer-associated thrombosis,” Dr. Luis Jara-Palomares gave a lecture on the...
Management of VTE beyond 12 months in patients with cancer-associated thrombosis
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...
Recording available for the “Long-term treatment & DDI implications in the management of CAT”
You can now watch the recording of “Long-term treatment & DDI implications in the management of...
Real-world CAT patient profile from the RIETE registry
During the ICTHIC webinar, “What is the profile of the real-world CAT patient?”, Dr. Laurent Bertoletti gave a...